Integrated BioPharma, Inc. INBP
0.17 USD 0.00 (+2.21%)
Nov 4, 2026, 3:59 PM EST
0.17375 Day range 0.17375
0.14 52-week range 0.42
- YTD
- -51.74%
- 1 year
- -42.08%
- Market cap
- 5.40M
- EPS (ttm)
- -0.09
- YTD return
- -51.74%
- 1-year return
- -42.08%
- Volume
- 900
- Avg volume
- 8.86K
- Open
- 0.17375
- Previous close
- 0.17
- Day's range
- 0.17375 – 0.17375
- 52-week range
- 0.14 – 0.42
2Y -0.1463 (-45.72%)
Financials — quick view
INBP Revenue — quarterly 12.91M
INBP Net income — quarterly -59.00K
INBP EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | 0.01 | — | — |
| Sep 20, 2024 | Jun 1, 2024 | 0.00 | 0.01 | — | — |
| May 10, 2024 | Mar 1, 2024 | 0.00 | 0.01 | — | — |
| Feb 12, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Sep 15, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026 
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions 
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Your note
Sign in to keep a note on INBP — it syncs with the Stock Master app.